Myriad Genetics
MYGN
#4109
Rank
$1.61 B
Marketcap
$19.94
Share price
1.12%
Change (1 day)
-23.19%
Change (1 year)

Market capitalization of Myriad Genetics (MYGN)

Market cap: $1.61 Billion

As of February 2023 Myriad Genetics has a market cap of $1.61 Billion. This makes Myriad Genetics the world's 4109th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Myriad Genetics from 2001 to 2023

End of year Market Cap

Year Market cap Change
2023$1.61 B37.42%
2022$1.17 B-46.65%
2021$2.20 B47.82%
2020$1.49 B-26.5%
2019$2.02 B-4.67%
2018$2.12 B-10.52%
2017$2.37 B108.51%
2016$1.14 B-63.09%
2015$3.09 B26.86%
2014$2.43 B56.96%
2013$1.55 B-29.95%
2012$2.21 B24.88%
2011$1.77 B-13.82%
2010$2.05 B-18.12%
2009$2.51 B-18.4%
2008$3.08 B49.62%
2007$2.05 B64.9%
2006$1.24 B53.44%
2005$0.81 B17.69%
2004$0.69 B98.13%
2003$0.34 B-11.49%
2002$0.39 B-68.45%
2001$1.25 B

End of Day market cap according to different sources

On Feb 1st, 2023 the market cap of Myriad Genetics was reported to be:

$1.59 Billion
by Yahoo Finance
$1.61 Billion
by CompaniesMarketCap
$1.61 Billion
by Nasdaq
$1.61 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$194.96 B 11,966.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$12.10 B 648.98%๐Ÿ‡บ๐Ÿ‡ธ USA
$21.69 B 1,242.38%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.34 M-99.42%๐Ÿ‡บ๐Ÿ‡ธ USA
$13.81 B 754.73%๐Ÿ‡บ๐Ÿ‡ธ USA